Literature DB >> 4333671

Amino acids and presynaptic inhibition in the rat cuneate nucleus.

N Davidson, C A Southwick.   

Abstract

1. Presynaptic inhibition was evoked in the rat cuneate nucleus by a peripheral conditioning stimulus. The dicarboxylic amino acid salts glutamate and aspartate and the neutral amino acids glycine and gamma-aminobutyric acid (GABA) were topically applied to a restricted area of the cuneate nucleus and their effects on both resting primary afferent terminal excitability and the increase in excitability of afferent terminals during presynaptic inhibition determined.2. Aspartate had no effect on either resting primary afferent terminal excitability or on the increase in excitability during presynaptic inhibition.3. Glycine reduced both resting primary afferent terminal excitability and presynaptic inhibition.4. Glutamate increased both resting primary afferent terminal excitability and presynaptic inhibition while GABA increased resting primary afferent terminal excitability but reduced the increase in excitability during presynaptic inhibition.5. The convulsant alkaloids picrotoxin (given intravenously) and bicuculline (topically applied) blocked presynaptic inhibition. The blocking action of picrotoxin was overcome by topical application of GABA but not glutamate.6. Simultaneous measurement of pre- and post-synaptic excitability in the cuneate nucleus showed that while glutamate increased excitability at both sites, GABA increased primary afferent terminal excitability but depressed post-synaptic excitability.7. It is concluded that glycine and glutamate exert non-specific actions on primary afferent terminals similar to their effects at post-synaptic sites elsewhere in the C.N.S. while GABA depolarizes primary afferent terminals by a specific action at the same receptor site as the presynaptic inhibitory transmitter. The possibility is discussed that the presynaptic inhibitory transmitter in the cuneate nucleus is GABA or a closely related substance.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4333671      PMCID: PMC1331654          DOI: 10.1113/jphysiol.1971.sp009683

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  PHARMACOLOGICAL STUDIES ON PRESYNAPTIC INHIBITION.

Authors:  J C ECCLES; R SCHMIDT; W D WILLIS
Journal:  J Physiol       Date:  1963-10       Impact factor: 5.182

2.  CELLULAR LOCALIZATION OF MONOAMINES IN THE SPINAL CORD.

Authors:  A CARLSSON; B FALCK; K FUXE; N A HILLARP
Journal:  Acta Physiol Scand       Date:  1964 Jan-Feb

3.  Facilitation of cortical responses by competing stimuli.

Authors:  G D DAWSON; V P PODACHIN; S W SCHATZ
Journal:  J Physiol       Date:  1963-04       Impact factor: 5.182

4.  Central inhibitory action attributable to presynaptic depolarization produced by muscle afferent volleys.

Authors:  J C ECCLES; R M ECCLES; F MAGNI
Journal:  J Physiol       Date:  1961-11       Impact factor: 5.182

5.  A morphological basis for pre-synaptic inhibition?

Authors:  E G GRAY
Journal:  Nature       Date:  1962-01-06       Impact factor: 49.962

6.  On the interaction of picrotoxin with GABA and glycine in the spinal cord.

Authors:  I Engberg; A Thaller
Journal:  Brain Res       Date:  1970-04-01       Impact factor: 3.252

7.  GABA, bicuculline and central inhibition.

Authors:  D R Curtis; A W Duggan; D Felix; G A Johnston
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

8.  Presynaptic and post-synaptic inhibition elicited in the cat's dorsal column nuclei by mechanical stimulation of skin.

Authors:  P Andersen; B Etholm; G Gordon
Journal:  J Physiol       Date:  1970-09       Impact factor: 5.182

9.  The effect of topically applied amino acids on primary afferent terminal excitability in the rat cuneate nucleus.

Authors:  N Davidson; C A Southwick
Journal:  J Physiol       Date:  1970-09       Impact factor: 5.182

10.  Bicuculline and inhibition in the thalamus.

Authors:  A W Duggan; H McLennan
Journal:  Brain Res       Date:  1971-01-08       Impact factor: 3.252

View more
  23 in total

1.  Pharmacological analysis of slow potentials recorded in frog olfactory bulb during natural stimulation.

Authors:  K G Gusel'nikova; L V Ivanova; G V Kipor
Journal:  Neurosci Behav Physiol       Date:  1976 Jan-Mar

2.  Dorsal root potentials and changes in extracellular potassium in the spinal cord of the frog.

Authors:  R A Nicoll
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

3.  Concerning the ionic basis of presynaptic inhibition.

Authors:  N Davidson; H K Simpson
Journal:  Experientia       Date:  1976-03-15

4.  GABA(A) receptor antagonism increases NMDA receptor inhibition by isoflurane at a minimum alveolar concentration.

Authors:  Robert J Brosnan
Journal:  Vet Anaesth Analg       Date:  2011-05       Impact factor: 1.648

5.  Comparison of bicyclic phosphorous esters with bicuculline and picrotoxin as antagonists of presynaptic inhibition in the rat cuneate nucleus.

Authors:  N Davidson; E I Macfarlane; D L Michie
Journal:  Experientia       Date:  1977-07-15

6.  Modulation of neuronal activity in dorsal column nuclei by upper cervical spinal cord stimulation in rats.

Authors:  C Qin; X Yang; M Wu; J P Farber; B Linderoth; R D Foreman
Journal:  Neuroscience       Date:  2009-08-07       Impact factor: 3.590

7.  Morphometric study of glycine-immunoreactive neurons and terminals in the rat cuneate nucleus.

Authors:  J H Lue; W F Shieh; S H Chen; J Y Shieh; C Y Wen
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

8.  The negative potential wave evoked in cuneate nucleus by stimulation of afferent pathways: its origins and susceptibility to inhibition.

Authors:  F Andres-Trelles; C M Cowan; M A Simmonds
Journal:  J Physiol       Date:  1976-06       Impact factor: 5.182

9.  The pharmacology and ionic dependency of amino acid responses in the frog spinal cord.

Authors:  J L Barker; R A Nicoll
Journal:  J Physiol       Date:  1973-01       Impact factor: 5.182

10.  Isethionate may not be an inert substitute for extracellular chloride in the central nervous system.

Authors:  N Bernardi; J A Assumpção; N Davidson; C G Dacke
Journal:  Experientia       Date:  1977-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.